Conscious Wealth Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.99M Buy
146,657
+3,279
+2% +$87.3K 2.22% 24
2025
Q4
$3.8M Buy
143,378
+2,264
+2% +$57.1K 2.28% 23
2025
Q3
$3.48M Buy
141,114
+157
+0.1% +$3.88K 2.06% 23
2025
Q2
$3.43M Buy
140,957
+706
+0.5% +$16.5K 2.19% 24
2025
Q1
$3.13M Buy
140,251
+35,807
+34% +$937K 2.17% 28
2024
Q4
$2.75M Buy
104,444
+2,574
+3% +$69.8K 1.86% 29
2024
Q3
$2.94M Buy
101,870
+437
+0.4% +$12.7K 2.02% 27
2024
Q2
$2.99M Sell
101,433
-1,456
-1% -$40.1K 2.15% 19
2024
Q1
$2.64M Buy
102,889
+67,975
+195% +$1.89M 2.01% 27
2023
Q4
$960K Buy
+34,914
New +$1.06M 0.77% 39

Other funds holding PFE

Conscious Wealth Investments's PFE Position: Q1 2026 in Review

Conscious Wealth Investments increased its Pfizer (PFE) stake by 2.3% in Q1 2026, buying an estimated $87.3K and bringing the position to 146,657 shares worth $3.99M. The position accounts for 2.22% of the portfolio, ranked #24.

Conscious Wealth Investments first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Conscious Wealth Investments held 146,657 shares of Pfizer worth $3.99M as of Q1 2026.
  • Conscious Wealth Investments bought 3,279 Pfizer shares in Q1 2026, an estimated $87.3K.
  • Pfizer made up 2.22% of Conscious Wealth Investments's portfolio in Q1 2026, its #24 holding.
  • Conscious Wealth Investments first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Conscious Wealth Investments's 13F filing for Q1 2026, filed 23 Apr 2026.